A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis
Conditions: Hemodialysis-Associated Amyloidosis; Dialysis Amyloidosis; Quality of Life Interventions: Device: Theranova 400; Device: Elisio-19H Sponsor: Selayang Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials